To address the unmet need for treatment modalities with increased effectiveness, immune-based therapies such as immune-checkpoint blockade, human papilloma virus-directed vaccines and adoptive T cell therapies have emerged as potential treatment options for advanced penile cancer.
[Nature Reviews Urology]
